Advanced processing solutions for Biopharmaceutical and Cosmetic Industry

Masco Group acquires KeyPlants AB

Masco Group acquires KeyPlants AB, a leading global provider of modular Life Science facilities

Masco Group, global provider of technological solutions for the pharmaceutical and biotech industries, has acquired a majority stake in Swedish company KeyPlants AB. The move will strengthen Masco’s leadership in engineering technologies for life sciences.

KeyPlants is a leading international industry partner for standardized as well as customized process-integrated modular prefabricated facility solutions. Based in Stockholm, the company has a fully integrated supply chain with more than 45 years of experience in project engineering, production and delivery, and has supplied more than 3,500 high-specification modules to at least 30 countries.

This partnership will strengthen Masco Group by combining its leadership in clean utilities and process technologies with KeyPlants’ expertise and innovative energy in prefabricated, modular facility solutions. It will support stronger value propositions for global supply chain challenges such as flexibility, reliability and fast-track manufacturing timelines to a global customer base of biopharmaceutical manufacturers and CDMOs focused on biologics, pharma and advanced therapy medicinal products (ATMPs), such as cell and gene therapies.

“We are extremely happy to partner with KeyPlants, as it will expand our capabilities, service and product offerings, and evolve our manufacturing capacity,” says Luca Borella, CEO of Masco Group. “We look forward to working with them to further accelerate the global adoption of their innovative fast-track facility solutions, which are an essential aspect in the life science industry.” He adds: “The companies share similar values, notably the commitment to teamwork, sustainability and customer care. Innovation is also an important synergetic element.”

“KeyPlants’ management and team are fully committed to this partnership with Masco Group,” says Jörgen Harrysson, Managing Director and Board Member of KeyPlants AB. “Its global presence and network enables KeyPlants to continue with our strategy to serve existing and new clients with our fast-track solutions, including customized facilities as well as standardized PODs. We are also thrilled to be able to expand our presence and offerings in North America, Europe and Africa.”

“We see KeyPlants and Masco Group as a perfect fit, and we are excited at the prospect of making KeyPlants and its skilled teams an integral part of the growth trajectory of the Masco Group family,” comments Frans K. A. Maas, Masco Group Board Member. “Masco Group is part of RSBG SE, a German-based long-term industrial partner of successful medium-sized companies, pursuing a buy-and-build strategy and focusing on competences and areas which are of great importance during global transformations. This acquisition supports the vision to become a technology-leading turnkey provider, in particular in the growing and demanding markets of biologics, vaccines and ATMPs.”

About Masco Group

Masco Group is an integrated solutions provider, partner to the top tier pharmaceutical and biotechnological companies. Its companies Stilmas, Olsa, DOC and BCD are leaders in clean utilities, process technologies and services. Headquartered in Milan-Italy, Masco Group has production sites and subsidiaries in Europe, America and Asia and serves more than 6000 clients globally, delivering around 300 projects per year.

More info: Masco Group

About KeyPlants

KeyPlants, headquartered in Stockholm, Sweden, is a leader in modular off-site construction for the life science industry, having delivered 100+ projects globally. Our customers benefit from KeyPlants’ vast experience and expertise, resulting in 30-50% shorter timelines and increased predictability with regards to schedule, cost, and quality. KeyPlants delivers turnkey facilities, including process equipment, utilities, and digital solutions.

More info: KeyPlants

Official updates on Coronavirus

You can find the official statement by Masco Group on Coronavirus here.

Masco Group and Olsa have been on the front line in the fight against the pandemic, never stopping working on our products, which are essential to the pharmaceutical industry. We supplied systems for the production of therapeutics used against Covid-19, such as antivirals, vaccines and antibodies.At our facilities around the world we have put in place all suitable protection measures, both for our employees and our clients.
Since traveling is difficult, we are promoting for our clients the use of technologies such as smart glasses and virtual reality for the testing and maintenance of our systems.

(altro…)

Events Calendar 2020

Find out what trade fairs, conferences, exhibitions and events we are participating in this year and don’t miss the opportunities to get to know us and our capabilities better.

March

ISPE EUROPE ANNUAL MEETING AND EXPO Madrid (Spain) 30 March – 2 April 2020

PHARMACOSMETECH Chartres (France) 31 March – 2 April 2020

May

INTERPACK Dusseldorf (Germany) 7 – 13 May 2020

June

FCE Pharma Sao Paulo (Brasil) 2 – 4 June 2020

October

Maghreb Pharma Alger (Algeria) 1 – 3 October 2020

P-Mec Worldwide Milan (Italy) 13 – 15 October 2020

November

ISPE ANNUAL MEETING AND EXPO  Philadelphia (USA) 1 – 4 November 2020

Pharmtech & Ingredients Moscow (Russia) 10 – 13 November 2020

P-Mec India New Delhi (India) 25 – 27 November 2020